Midstage trial proceeds for sickle cell disease drug

01/22/2013 | Pharmaceutical Business Review Online

Enrollment has been wrapped up for a midstage study evaluating the safety, efficacy and pharmacokinetics of GlycoMimetics' experimental drug GMI-1070 among sickle cell disease patients in vaso-occlusive crisis. Preliminary findings from the 76-patient trial could be released next quarter.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA